TIGERMED
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization providing whole process clinical trial services for the research and development of pharmaceutical products. Since its inception, the company is dedicated to the provision of medical research and development services that enables clients to reduce the risk and cost of R&D, while advancing the process of marketization. With 21 sub-companies spread across 43 main cities in the world, including China, America, C... anada, Japan, Australia, Korea, and more, Tigermed owns a professional team of more than 900 people that constructs the operating instruction that meets international standards. Tigermed has succeeded in providing more than 300 customers with over 300 clinical trial services by the end of 2013. For its participation in 42 domestic drugs, Tigermed is honoured as an “Innovation-type CRO.”
TIGERMED
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.tigermed.net
Total Employee:
5001+
Status:
Active
Contact:
+86-571-28887227
Email Addresses:
[email protected]
Total Funding:
8.3 M USD
Technology used in webpage:
SPF LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CloudFront Java EE Google No Translate
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-10-01 | DreamCIS | DreamCIS acquired by Tigermed | N/A |
| 2014-05-08 | Frontage Laboratories | Frontage Laboratories acquired by Tigermed | 50.25 M USD |
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Venture Round - Tigermed
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Tigermed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-07 | LTZ Therapeutics | Tigermed investment in Seed Round - LTZ Therapeutics | 17 M USD |
| 2021-12-21 | BioInno | Tigermed investment in Series A - BioInno | N/A |
| 2021-11-15 | Jisi Yingda | Tigermed investment in Series B - Jisi Yingda | N/A |
| 2021-09-13 | CytoLynx Therapeutics | Tigermed investment in Funding Round - CytoLynx Therapeutics | 45 M USD |
| 2021-07-13 | Adlai Nortye | Tigermed investment in Series D - Adlai Nortye | 100 M USD |
| 2021-03-09 | Gmax Biopharm | Tigermed investment in Series C - Gmax Biopharm | 78 M USD |
| 2020-10-06 | Hinova Pharma | Tigermed investment in Series C - Hinova Pharma | 1000 M CNY |
| 2020-08-31 | Adlai Nortye | Tigermed investment in Series C - Adlai Nortye | 100 M USD |
| 2020-06-28 | Asieris Pharmaceuticals | Tigermed investment in Series C - Asieris Pharmaceuticals | 290 M CNY |
| 2020-02-18 | CANbridge Pharmaceuticals | Tigermed investment in Series D - CANbridge Pharmaceuticals | 98 M USD |
Official Site Inspections
http://www.tigermed.net Semrush global rank: 3.88 M Semrush visits lastest month: 3.31 K
Unable to get host informations!!!
